UCB
A U.S. Epilepsy and Rare Disease Communications Lead will develop and execute integrated communications strategies to support the U.S. epilepsy and rare disease portfolio. This role involves partnering across functions to deliver compliant, patient-centered storytelling while managing external agencies and engaging with healthcare professionals and advocacy communities.
Headquarters
Brussels, Brussels, Belgium
Company Size
5001-10000 employees
Founded
1928
UCB a global biopharmaceutical leader focuses on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for UCB.
Associate Director, US Neuroscience Communications
Novartis
Director, US Neuroscience Communications
Novartis
Director, Rare Disease Communications, EUCAN & International
lifelancer
Rare Disease Specialist
BioCryst Pharmaceuticals
Key Account Manager Rare Disease
Ipsen
Medical Science Liaison Rare Disease & Epilepsy Greece
City of Winnipeg